The HSE has confirmed that contingency planning is underway to minimise the impact on patient care caused by a temporary reduction in the supply of outsourced chemotherapy products being experienced this week. We would stress, however, that the vast majority of patients undergoing chemotherapy treatment will not experience any interruption or changes to their treatment plan as a result of this issue.
The HSE is liaising with the supplier concerned and understands that they expect the capacity issue to be resolved by early next week. Medical teams in each of the hospitals are determining the clinical needs of those patients involved and decisions regarding re-scheduling are being prioritised. Hospitals are in direct contact with those patients affected to re-schedule appointments as appropriate. For a very small number of patients, whose clinical needs require immediate access to the drugs as planned, treatment options are being offered in alternative hospitals to ensure that they are seen in a timely manner.
Any concern this situation will cause to patients is regrettable, but we would stress that all hospitals affected are working to minimise the overall impact. We would further stress that hospitals will make direct contact with those patients affected and patients are advised to attend for treatment as arranged unless they are informed otherwise.
Last updated on: 18 / 05 / 2017